OPKO Health Inc. (OPK) News
Filter OPK News Items
OPK News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
OPK News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest OPK News From Around the Web
Below are the latest news stories about OPKO HEALTH INC that investors may wish to consider to help them evaluate OPK as an investment opportunity.
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceMIAMI, Jan. 09, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 43rd Annual J.P. Morgan Healthcare Conference, being held January 13-16, 2025 at Westin St. Francis hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 15th at 3:00 p.m. Pacific time. The presentation will be webcast live and available for replay in the Investors section of OPKO Health’ |
Here's Why You Should Retain OPKO Health Stock in Your PortfolioOPK's growth is fueled by Rayaldee's success and accelerated clinical trials. However, stiff competition and overdependence on its lead product are concerns. |
OPKO Health Announces Progress in EBV Vaccine Study, Stock GainsOPK aims to advance a novel vaccine candidate for EBV infection, provide protective immunity to patients and prevent these diseases. |
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with MerckEpstein-Barr virus (EBV) causes infectious mononucleosis and is associated with several types of cancer and multiple sclerosisThere are no current treatments or vaccines for EBVFirst participant dosed with novel investigational EBV vaccine targeting multiple viral proteins in Phase I study WESTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), announces dosing of the first participant in the Phase I study (NCT06655324) of an EBV vaccine ca |
Is OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now?We recently published a list of 11 Best NASDAQ Penny Stocks To Buy Right Now. In this article, we are going to look at where OPKO Health, Inc. (NASDAQ:OPK) stands against other best NASDAQ penny stocks to buy right now. The NASDAQ Stock Market is home to some of the world’s largest companies in the world […] |
NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online RetailerNextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today announced a significant expansion of its e-Commerce development program in China having received vendor approval from JD.com, the world's second largest e-Commerce market, and the largest self-operated e-Commerce retailer in China (Source: Statista), for the listing and sales of OPKO Health Europe ("OPKO") branded health & wellness and veterinary care products. |
OPKO Health (NASDAQ:OPK) investors are sitting on a loss of 59% if they invested three years agoIf you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But... |
Sleep Number, Getty Images, and More Stocks See Action From Activist InvestorsStadium Capital raised its stake in the bed maker. Starboard Value disclosed a new position in Healthcare Realty Trust. Plus, Paysafe, Getty Images, and GeneDx. |
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceMIAMI, Nov. 20, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 36th Annual Healthcare Conference, being held December 3-5, 2024 at the Lotte New York Palace Hotel in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside chat on Wednesday, December 4th at 1:30 p.m. Eastern time. The fireside chat will be webcast live and available for replay in the In |
NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoNextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-commerce provider, today announced that it is participating in the 2024 China International Natural Health & Nutrition Expo (NHNE), Asia's largest exhibition focused on the sales and marketing of health, nutrition and dietary supplement products, as the Company continues to ramp-up sales and promotional activities in China. |